IDH2 and central nervous system cancer: Both IDH-mutant gliomas, oligodendrogliomas and astrocytomas, were reported to commit to the oligodendrocyte lineage, and may be blocked during the premyelination phase due to hypermethylation and downregulated expression of myelination regulators and myelin components [29].